Literature DB >> 32074480

COVID-19, Australia: Epidemiology Report 3 (Reporting week ending 19:00 AEDT 15 February 2020).

.   

Abstract

This is the third epidemiological report for coronavirus disease 2019 (COVID-19), previously known as novel coronavirus (2019-nCoV), from the virus now known as SARS-CoV-2, reported in Australia as at 19:00 Australian Eastern Daylight Time [AEDT] 15 February 2020. It includes data on the COVID-19 Australian cases, the international situation and current information on the severity, transmission and spread. © Commonwealth of Australia CC BY-NC-ND.

Entities:  

Keywords:  2019-nCoV; Australia; COVID-19; SARS-CoV-2; acute respiratory disease; case definition; coronavirus disease 2019; epidemiology; novel coronavirus

Mesh:

Year:  2020        PMID: 32074480     DOI: 10.33321/cdi.2020.44.15

Source DB:  PubMed          Journal:  Commun Dis Intell (2018)        ISSN: 2209-6051


  3 in total

Review 1.  International Public Health Responses to COVID-19 Outbreak: A Rapid Review.

Authors:  Parinaz Tabari; Mitra Amini; Mohsen Moghadami; Mahsa Moosavi
Journal:  Iran J Med Sci       Date:  2020-05

2.  COVID-19 seeding time and doubling time model: an early epidemic risk assessment tool.

Authors:  Lei Zhou; Jiang-Mei Liu; Xiao-Ping Dong; Jennifer M McGoogan; Zun-You Wu
Journal:  Infect Dis Poverty       Date:  2020-06-23       Impact factor: 4.520

Review 3.  Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis.

Authors:  Israel Júnior Borges do Nascimento; Nensi Cacic; Hebatullah Mohamed Abdulazeem; Thilo Caspar von Groote; Umesh Jayarajah; Ishanka Weerasekara; Meisam Abdar Esfahani; Vinicius Tassoni Civile; Ana Marusic; Ana Jeroncic; Nelson Carvas Junior; Tina Poklepovic Pericic; Irena Zakarija-Grkovic; Silvana Mangeon Meirelles Guimarães; Nicola Luigi Bragazzi; Maria Bjorklund; Ahmad Sofi-Mahmudi; Mohammad Altujjar; Maoyi Tian; Diana Maria Cespedes Arcani; Dónal P O'Mathúna; Milena Soriano Marcolino
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.